Kaléo, a privately held pharmaceutical company, plans to offer an authorized generic of its Evzio (naloxone HCl injection) take home naloxone product at a list price of $178 per carton (each carton contains two auto-injectors).  Offered through Kaléo subsidiary IJ Therapeutics, the authorized generic will be made available in midyear 2019 well in advance of Evzio’s patent expirations.…